contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-21032025-bioporto-pharma-equity-group-flugger-group-og-windowmaster

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Head of Research, Stables

Rasmus Køjborg

CEO, Sweden

Claus Thestrup

BioPorto is a Danish in-vitro diagnostics company with headquarters in Copenhagen, Denmark. The company was founded in 2000. BioPorto has one marketed product, the NGAL test, for early diagnosis of acute kidney injury (AKI), which is commercially available in Europe, Canada, Asia, and Israel.

It has received breakthrough designation from the FDA for AKI in the pediatric indication, for which it is currently conducting data analysis following the completion of enrollment of patients for its Phase 3 study which will lead to an expected application to FDA. Future plans include further FDA submission for adult indication as well as other markets. 

BioPorto

Pharma Equity Group develops medicines for the treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The Company uses repositioning of existing medicines and takes drug candidates to a clinical Phase III stage, after which they are handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the Company.

Pharma Equity Group

Flügger develops, produces, markets, and sells interior and exterior decorative paint, wood stains, filler, and tools; selling to professional painters, private customers, and builder’s merchants. Flügger originates from Denmark and is listed on the Nasdaq OMX Copenhagen Stock Exchange.

Flügger has a strong market position in the Nordic markets, where it is the market leader in Denmark. Its physical Flügger Farver stores are well known throughout the Nordic region and are the company’s primary sales channel; however, Flügger also has private label sales via builder’s merchants as well as developing e-commerce capabilities.

Flügger’s position in the Nordics is relatively stable, whereas the company has growth via export markets and its own presence in Eastern Europe, with a long history in Poland and by the acquisitions of Unicell and Eskaro.

Flügger Group

WindowMaster was founded in Denmark in 1990 with the ambition of becoming a strong market leader in the fenestration industry. In 2015, CEO Erik Boyter led a management buy-in and listed the company on the Nasdaq First North Growth Market in Copenhagen in 2020. It has been a family-controlled, listed company since then. 

WindowMaster offers advanced ventilation strategies, enabling the construction industry to significantly reduce its carbon footprint. Driven by the purpose ‘To create a better world where every person has fresh air indoors and a safe built environment’, the company develops, manufactures, distributes facade and roof automation solutions for hybrid ventilation, natural ventilation, and smoke ventilation systems. WindowMaster’s actuators and control systems enable the flow of fresh air, while actuators ensure window automation. The company also provides project design assistance, ventilation calculation, installation, commissioning, integration opportunities and system training. 

The company benefits from strong structural tailwinds in the European building industry for both renovation and newbuild. Both applications are supported by increasing regulatory focus on energy efficiency and a more sustainable construction industry. Buildings account for roughly 40% of global energy consumption, with more than two-thirds related to heating, ventilation, air conditioning, and lighting — making WindowMaster’s solutions a high-impact lever for energy reduction.  

Over the past four years (2020–2024), WindowMaster has delivered profitable growth with a 12% revenue CAGR, while improving both EBITDA and cash flow. The company’s performance has shown greater resilience than the broader building materials sector, underpinned by its exposure to the more stable renovation segment, the highly regulated smoke control market, and growing investments in the green transition. 

A disciplined capital allocation strategy has created substantial value through investments in innovation, own production capacity, and the global sales organisation. These initiatives have cemented WindowMaster’s strong market position across core markets in Europe and North America. 

With a robust platform for both organic and inorganic growth, WindowMaster is well positioned to create long-term shareholder value. In 2025, the company paid its first dividend since the IPO, reflecting its healthy financial foundation and commitment to shareholder value. 

WindowMaster International

Dagens aktienyheder 21.03.2025: Bioporto, Pharma Equity Group, Flügger Group og Windowmaster

Bioporto: Wrap up fra g&#xe5;rdagens interview med CEO Peter M&#xf8;rch Eriksen og CFO Niels H&#xf8;y Nielsen efter afl&#xe6;ggelsen af &#xe5;rsregnskabet for 2024 og guidance for 2025 - l&#xe6;s og lyt her: <a href="https://www.inderes.dk/analyst-comments/bioporto-wrap-up-fra-interview-med-ceo-peter-m-eriksen-og-cfo-niels-h-nielsen" target="_blank" rel="noopener">kommentar og interview Bioporto</a>
Pharma Equity Group: Wrap up fra g&#xe5;rdagens interview med CEO Thomas Kaas Sels&#xf8; efter afl&#xe6;ggelse af &#xe5;rsregnskabet for 2024 samt vigtige milestones i 2025 - l&#xe6;s og lyt her: <a href="https://www.inderes.dk/analyst-comments/pharma-equity-group-wrap-up-fra-interview-med-ceo-thomas-k-selso" target="_blank" rel="noopener">kommentar og interview med PEG</a>
Fl&#xfc;gger offentliggjorde i g&#xe5;r sin kvartalsmeddelelse for 3. kvartal 2024/25. Opdateringen d&#xe6;kker perioden 1. maj 2024 til 31. januar 2025, og indeholder alene oms&#xe6;tningstal og en kort opdatering, og er alts&#xe5; ikke et fuldt regnskab. I Q3 2024/25, der historisk er &#xe5;rets mindste kvartal, omsatte Fl&#xfc;gger for DKK 447 mio., hvilket er en lille fremgang p&#xe5; 1% i forhold til samme kvartal &#xe5;ret f&#xf8;r hvor oms&#xe6;tningen l&#xe5; p&#xe5; DKK 441 mio. Det d&#xe6;kker over fremgang i Polen og Sverige, mens de &#xf8;vrige markeder er n&#xe6;sten u&#xe6;ndret. Vil du h&#xf8;re mere om kvartalet har vi i n&#xe6;ste uge &#x2013; tirsdag d. 25. marts kl. 13.00 - forn&#xf8;jelsen at invitere til en gennemgang med CEO Sune Schnack og CFO Lucas Eichild. Her vil der ogs&#xe5; v&#xe6;re mulighed for at stille sp&#xf8;rgsm&#xe5;l til ledelsen. Tilmelding her: <a href="https://www.inderes.dk/videos/flugger-praesentation-af-kvartalsopdatering-for-3-kvartal-202425" target="_blank" rel="noopener">Fl&#xfc;gger event</a>
WindowMaster var i g&#xe5;r repr&#xe6;senteret af selskabets ledelse til en gennemgang af rekordresultaterne for 2024 og forventningerne til 2025. Pr&#xe6;sentationen blev efterfulgt af en Q&amp;A session, hvor der var en r&#xe6;kke sp&#xf8;rgsm&#xe5;l fra tilh&#xf8;rerne, herunder om de nuv&#xe6;rende markedsudsigter. Se eller gense pr&#xe6;sentationen her (engelsk): <a href="https://www.inderes.dk/videos/windowmaster-full-year-2024-results-presentation" target="_blank" rel="noopener">Windowmaster interview</a>
<a class="eLkeKfLANpCeIaaehlTorHkfbdUHqQFXesk " tabindex="0" href="https://www.linkedin.com/company/hcandersencapital/" target="_self" data-test-app-aware-link>HC Andersen Capital</a> modtager betaling fra de n&#xe6;vnte selskaber for en digital IR/Corporate Visibility abonnementsaftale.&#xa0; /<a id="ember858" class="ember-view" href="https://www.linkedin.com/in/rasmus-koejborg/">Claus Thestrup</a> d. 21/03-2025 kl. 8:54

Stay up to date